A1AT | | Target | Disease | Inflammation | | | | | | |
A1AT | | Target | Disease | Liver Disease | | | | | | |
A1AT | | Target | Disease | Heart Disease | | | | | | |
A1AT | | Target | Disease | Warts | | | | | | |
A-Methapred (Methylprednisolone Sodium Succinate)- FDA | | Drug | Drug | Adalimumab (Humira)- FDA | | | | | | |
744.1 | | Target | Disease | Carcinoma | | | | | | |
744.1 | | Target | Disease | Acute Promyelocytic Leukemia | | | | | | |
744.1 | | Target | Disease | Chronic Obstructive Pulmonary Disease | | | | | | |
744.1 | | Target | Disease | Stroke | | | | | | |
744.1 | | Target | Target | Adiponectin | | | | | | |
744.1 | | Target | Target | 464.1 | | | | | | |
744.1 | | Target | Disease | Hepatitis | | | | | | |
744.1 | | Target | Disease | Cardiac Arrest | | | | | | |
744.1 | | Target | Disease | Dyslipidemia | | | | | | |
744.1 | | Target | Disease | Leukemia | | | | | | |
744.1 | | Target | Disease | Inflammation | | | | | | |
744.1 | | Target | Disease | Liver Disease | | | | | | |
744.1 | | Target | Disease | Heart Disease | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Central Nervous System Diseases | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Obesity | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Target | ERK1 | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Target | 5-Hydroxytryptamine 2a Receptor | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Target | Collagen | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Migraine | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Amyotrophic Lateral Sclerosis | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Target | D(2) Dopamine Receptor | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Target | Elastase | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Liver Disease | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Heart Disease | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Target | Collagen | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Target | Sphingomyelinase | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Target | EGF | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Disease | Mania | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Disease | Psoriasis | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Disease | Autism | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Disease | Pain | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Target | BDNF | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Disease | Seizures | | | | | | |
5-Hydroxytryptamine 2a Receptor | | Target | Disease | Inflammation | | | | | | |
464.1 | | Target | Disease | Hypotension | | | | | | |
464.1 | | Target | Disease | Cholesterol | | | | | | |
464.1 | | Target | Disease | Leukemia | | | | | | |
464.1 | | Target | Disease | Asthma | | | | | | |
464.1 | | Target | Disease | Inflammation | | | | | | |
4-Mercaptopyridine | | Drug | Disease | Cancer | | | | | | |
4-Mercaptopyridine | | Drug | Drug | 4-Mercaptobenzoic Acid | | | | | | |
4-Mercaptopyridine | | Drug | Disease | Leukemia | | | | | | |
4-Mercaptopyridine | | Drug | Drug | Doxorubicin | | | | | | |
4-Mercaptopyridine | | Drug | Disease | Glioblastoma | | | | | | |
4-Mercaptobenzoic Acid | | Drug | Disease | Hepatitis | | | | | | |